Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomas
10.3390/cancers10040089
Saved in:
Main Authors: | Ramayanti, O, Brinkkemper, M, Verkuijlen, S.A.W.M, Ritmaleni, L, Go, M.L, Middeldorp, J.M |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/178248 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The role of nk cells in ebv infection and ebv-associated npc
by: Png, Yi Tian, et al.
Published: (2022) -
The In vitro study of epstein-Barr Virus (EBV) infection to human primary T-Lymphocytes
by: Putrada Ninla-aesong
Published: (2010) -
Expression of EBV genes in nasopharyngeal carcinoma
by: LI BOJUN
Published: (2010) -
Reticular and Myxoid Non-keratinizing Nasopharyngeal Carcinoma: An Unusual Case Mimicking a Salivary Gland Carcinoma
by: Petersson, F., et al.
Published: (2016) -
The protective role of epstein-barr virus (EBV) - specific cytotoxic T lymphocytes in immunocompromised hosts with EBV infection
by: Patcha Incomserb
Published: (2012)